DaVita
Clinical Research® (DCR®), a specialty contract research
organization with services spanning the full spectrum of drug and device
development, announced today that Dr. Jolene K. Berg, M.D., has been
appointed medical director of the DaVita Clinical Research Phase I
center in Minneapolis.
“Dr. Berg brings a depth of experience in clinical trial design and
execution in a wide range of early clinical studies,” said Amy Young,
vice president and general manager of DCR. “Her experience augments
DCR’s capabilities to manage co-morbid conditions in early clinical
trials. She will be responsible for overseeing all clinical aspects of
Phase I trials and providing medical monitoring services across study
sites.”
Dr. Berg will serve as principal investigator for Phase I-IIa studies
being conducted in DCR’s inpatient site. Previously Dr. Berg was
director of medical affairs at PRACS
Institute, where she was responsible for the planning and
development of clinical studies in Phase I through Phase IV with an
emphasis on endocrinology and innovator drugs.
“I am excited to join the early clinical research unit at DCR,” said Dr.
Berg. “I look forward to contributing to their long-standing history of
providing operational and scientific excellence.”
Dr. Berg completed her medical degree at the University of Minnesota
Medical School in Minneapolis; she fulfilled a family medicine residency
training at St. John’s Hospital in St. Paul, Minn., and at the
University of Washington in Seattle. Dr. Berg is also a Certified
Physician Investigator through the Academy of Pharmaceutical Physicians
and Investigators.
To learn more about DCR and upcoming clinical research trials, visit participateDaVita.com
or DCR
on Facebook.
DaVita, DaVita Clinical Research and DCR are registered trademarks of
DaVita HealthCare Partners Inc. All other trademarks are the property of
their respective owners.
About DaVita
DaVita is the dialysis division of DaVita HealthCare Partners Inc., a
Fortune 500® company that, through its operating divisions, provides a
variety of health care services to patient populations throughout the
United States and abroad. A leading provider of kidney care in the
United States, DaVita delivers dialysis services to patients with
chronic kidney failure and end stage renal disease. DaVita strives to
improve patients’ quality of life by innovating clinical care, and by
offering integrated treatment plans, personalized care teams and
convenient health-management services. As of December 31, 2012, DaVita
operated or provided administrative services at 1,954 outpatient
dialysis centers located in the United States serving approximately
153,000 patients. The company also operated 36 outpatient dialysis
centers located in eight countries outside the United States. DaVita
supports numerous programs dedicated to creating positive, sustainable
change in communities around the world. The company’s leadership
development initiatives and social responsibility efforts have been
recognized by Fortune, Modern Healthcare, Newsweek and WorldBlu. For
more information, please visit DaVita.com.
About DaVita Clinical Research (DCR)
DaVita
Clinical Research (DCR), a wholly owned subsidiary of DaVita
HealthCare Partners, Inc.,uses its extensive, applied database and
real-world healthcare experience to assist pharmaceutical and medical
device companies in the design, recruitment and completion of
retrospective, prospective pragmatic and clinical trials. DCR’s
scientific and clinical expertise spans the lifecycle of product
development with more than 150 client companies. DCR’s Biorepository, Early
Clinical Research unit (Phase I-IIa) and Clinical
Development (Phase IIb through post-marketing) network of physicians
and investigative sites, data research, Health
Economics & Outcomes Research, Central
Laboratory, and Medical
Communications are focused on providing world-class research in both
complex/specialty populations and therapeutic areas, and especially in
CKD and ESRD populations. To learn more about DCR, visit www.davitaclinicalresearch.com.
